Search Within

Tiffany A Traina

  1. "Mark Robson"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (12)
  3. Review (1)
Groups
  1. Breast Medicine Service (27)
  2. Department of Medicine (27)
  3. Population Sciences Research Program (27)
  4. Solid Tumor Oncology Division (27)
  5. Survivorship Research (27)
  6. Biostatistics Service (20)

More Groups

People
  1. Mark Robson (27)
  2. Sujata Patil (12)
  3. Larry Norton (10)
  4. Jorge Reis-Filho (9)
  5. Chau Dang (8)
  6. Clifford Hudis (7)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (5)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (4)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Breast Cancer Research and Treatment (2)
  5. Cochrane Database of Systematic Reviews (2)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (3)
  4. Nature Publishing Group (3)
  5. Springer (3)
  6. John Wiley & Sons (2)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
    Journal Article

    Mai, N.; Myers, S.; Shen, S.; Downs-Canner, S.; Robson, M.; Norton, L.; Chen, Y.; Traina, T.; Abuhadra, N.
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Standardizing height and weight measurement for treatment calculations in adult patients with cancer
    Meeting Abstract

    Tesoriero, L.; Rodriguez, E.; Connor, M.; Garcia, J.; Lin, T.; Robson, M.; Traina, T.; Collum, K.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Meeting Abstract

    Abuhadra, N.; Chen, Y.; Plitas, G.; Razavi, P.; Pareja, F.; Reis-Filho, J. S.; Wen, H. Y.; Khan, A. J.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • PD-L1 expression in metaplastic breast carcinoma using the PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical assays
    Journal Article

    Grabenstetter, A.; Jungbluth, A. A.; Frosina, D.; Hoda, R.; Dos Anjos, C. H.; Patil, S.; Sevilimedu, V.; Weigelt, B.; Reis-Filho, J. S.; Zhang, H.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • PARP (poly ADP-ribose polymerase) inhibitors for locally advanced or metastatic breast cancer
    Review

    Taylor, A. M.; Chan, D. L. H.; Tio, M.; Patil, S. M.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Cochrane Database of Systematic Reviews (2021)

    Fulltext@MSK | Save